StonvexLoading…
StonvexStonvexStonvexCore line items from CRS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $869.85M | $2.27B | $1.46B | $733.70M | $2.88B |
Operating Income | Not available | $495.10M | $308.60M | $153.30M | $521.80M |
Net Income | Not available | $367.40M | $227.80M | $122.50M | $376.00M |
EPS (Diluted) | $3.10 | $7.29 | $4.52 | $2.43 | $7.42 |
Total Assets | Not available | $3.68B | $3.50B | $3.40B | $3.49B |
Total Liabilities | Not available | $1.61B | $1.52B | $1.49B | $1.60B |
Cash & Equivalents | Not available | $294.80M | $231.90M | $208.00M | $315.50M |
Free Cash Flow OCF − CapEx | Not available | $207.30M | $82.50M | $-3.40M | $286.10M |
Shares Outstanding | Not available | 49.69M | 49.81M | 49.74M | 49.71M |